Dec 31, 2013

United Therapeutics Q4 2013 Earnings Report

Total Revenue
$289M
Previous year: $244M
+18.5%
EPS
$3.19
Previous year: $2.5
+27.6%
Gross Profit
$250M
Previous year: $206M
+21.4%
Cash and Equivalents
$284M
Previous year: $159M
+78.4%
Total Assets
$2.09B
Previous year: $1.63B
+28.3%

United Therapeutics

United Therapeutics